Xpress Genomics
PrivateCompany Overview
Xpress Genomics is a biotechnology company that provides scalable and high-quality genomics services, specializing in single-cell RNA-sequencing for researchers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
genomics servicessingle-cell RNA sequencingscRNA-seqfull-length scRNA-seqcontract research organizationCROsequencing as a servicenext-generation sequencingNGShigh-throughput sequencingspatial transcriptomicsbulk RNA sequencingbioinformatics servicesproteomics servicesOlink service providerATAC-seqepigenomics servicesNGS library preparation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xpress Genomics Comparables
Compare Xpress Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Single Cell Discoveries | 86% | |
| SingulOmics Corporation | 84% | |
| Admera Health | 83% | |
Xpress Genomics Funding Rounds
Historical fundraising activity
Xpress Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xpress Genomics's valuation, stock price, and market status.
See something wrong or outdated?